Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway (vol 96, 884, 2017)

被引：0
|
作者：
Zhang, Lei [1 ]
He, Xiaowei [2 ]
Jin, Ting [3 ]
Li, Gang [4 ]
Jin, Zhenlin [5 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou 325000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Eye Hosp, Wenzhou 325000, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Operating Room, Wenzhou 325000, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Chemoradiat Oncol, Wenzhou 325000, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hematol, Wenzhou 325000, Zhejiang, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 162卷
关键词：
D O I：
10.1016/j.biopha.2023.114656
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long non-coding RNA LINC00467 regulates hepatocellular carcinoma progression by modulating miR-9-5p/PPARA expression (Expression of Concern of Vol 9, art no 190074, 2019)
    Open Biology Editorial Team
    OPEN BIOLOGY, 2023, 13 (08)
  • [32] HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
    Chen, Tianxiang
    Liu, Runkun
    Niu, Yongshen
    Mo, Huanye
    Wang, Hao
    Lu, Ye
    Wang, Liang
    Sun, Liankang
    Wang, Yufeng
    Tu, Kangsheng
    Liu, Qingguang
    CELL DEATH & DISEASE, 2021, 12 (12)
  • [33] HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
    Tianxiang Chen
    Runkun Liu
    Yongshen Niu
    Huanye Mo
    Hao Wang
    Ye Lu
    Liang Wang
    Liankang Sun
    Yufeng Wang
    Kangsheng Tu
    Qingguang Liu
    Cell Death & Disease, 12
  • [34] Long non-coding RNA PART1 promotes intervertebral disc degeneration through regulating the miR-93/MMP2 pathway in nucleus pulposus cells
    Gao, Dongmei
    Hao, Long
    Zhao, Zilong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (01) : 289 - 299
  • [35] Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway
    Tu, Jianfei
    Wu, Fazong
    Chen, Li
    Zheng, Liyun
    Yang, Yang
    Ying, Xihui
    Song, Jingjing
    Chen, Chunmiao
    Hu, Xianghua
    Zhao, Zhongwei
    Ji, Jiansong
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [36] Long Non-Coding RNA PVT1/miR-150/HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma
    Xu, Yunxiuxiu
    Luo, Xinxi
    He, Wenguang
    Chen, Guangcheng
    Li, Yanshan
    Li, Wenxin
    Wang, Xicheng
    Lai, Yu
    Ye, Yibiao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (04) : 1403 - 1419
  • [37] A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway
    Shen, Yuan
    Liu, Shanshan
    Yuan, Hanyu
    Ying, Xiaomin
    Fu, Hanjiang
    Zheng, Xiaofei
    TUMOR BIOLOGY, 2017, 39 (05)
  • [38] Long non-coding RNA MKLN1-AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR-654-3p, thereby promoting hepatoma-derived growth factor expression
    Gao, Wanjun
    Chen, Xiaohua
    Chi, Wei
    Xue, Ming
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (05) : 1743 - 1754
  • [39] Long non-coding RNA Dleu2 affects proliferation, migration and invasion ability of laryngeal carcinoma cells through triggering miR-16-1 pathway
    Xie, Z-Z.
    Xia, Z-C.
    Song, Y-X.
    Li, W.
    Tan, G-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 1963 - 1970
  • [40] Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway
    Gao, Zejun
    Wang, Hai
    Li, Hangyu
    Li, Min
    Wang, Jia
    Zhang, Wenwen
    Liang, Xiubin
    Su, Dongming
    Tang, Jinhai
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (05) : 2081 - 2090
12345